○Natsuko Kato1, Kanako Muraga1,7, Yoshinori Hirata1,2, Akihiro Shindo1,3, Keita Matsuura1, Yuichiro Ii1, Mariko Shiga2, Ken-ichi Tabei3, Masayuki Satoh2,3, Satoshi Fujita4, Yoshihiko Kagawa4, Eitaro Fujii4, Masaaki Ito4, Maki Umino5, Masayuki Maeda5,6, Hidekazu Tomimoto1,2 (1.Department of Neurology, Mie University, Japan, 2.Dementia Center, Mie University, 3.Department of Dementia Prevention and Therapeutics, Mie University, 4.Department of Cardiology, and Nephrology, Mie University, 5.Department of Radiology, Mie University, 6.Department of Advanced Diagnostic Imaging, Graduate School of Medicine, Mie University, 7.Department of Neurologic Science, Nippon Medical School)
Session information
Oral Session
[O-12] Oral Session 12 Cerebrovascular disease3
Thu. May 20, 2021 9:45 AM - 10:45 AM Room 02 (ICC Kyoto 1F Annex Hall 1)
Chair:Imai Keisuke(Department of Neurology and Stroke Treatment, Kyoto First Red Cross Hospital)
○Naoya Yamazaki1, Ryousuke Doijiri1, Ayane Ohyama1, Kouhei Takikawa1, Takuji Sonoda1, Mitsunobu Satou1, Momoyo Oda2, Ken Takahashi1, Naoto Kimura3, Hiroaki Takahashi1, Takahiko Kikuchi1 (1.Department of Neurology, Iwate prefectural central hospital, Japan, 2.Department of Rehabilitation, Iwate prefectural central hospital, 3.Department of Neurosurgery, Iwate prefectural central hospital)
○Miyu Usui, Masayuki Suzuki, Kumiko Miura, Tadashi Ozawa, Kosuke Matsuzono, Takafumi Mashiko, Reiji Koide, Shigeru Fujimoto, Ryota Tanaka (Jichi Medical University Hospital Department of Neurology, Japan)
○Takuma Kato1, Atsushi Yamamoto1, Keisuke Imai1, Naoki Tokuda1, Tetsuya Ioku1, Toshi Sai1, Masanori Cho1, Kanako Menjo1, Masashi Hamanaka2, Kazuma Tsuto3, Ryota Ueda4 (1.Department of Neurology and Stroke Treatment, Kyoto First Red Cross Hospital, Japan, 2.Department of Neurology, Kyoto Second Red Cross Hospital, 3.Department of Neurosurgery, Seisho Hospital, 4.Department of Neurology, North Medical Center Kyoto Prefectural University of Medicine)